LB Group Past Earnings Performance
Past criteria checks 5/6
LB Group has been growing earnings at an average annual rate of 6.7%, while the Chemicals industry saw earnings growing at 8.4% annually. Revenues have been growing at an average rate of 21% per year. LB Group's return on equity is 13.4%, and it has net margins of 13.1%.
Key information
6.7%
Earnings growth rate
3.0%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 21.0% |
| Return on equity | 13.4% |
| Net Margin | 13.1% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How LB Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 27,080 | 3,557 | 1,678 | 918 |
| 31 Dec 23 | 26,765 | 3,185 | 1,594 | 1,014 |
| 30 Sep 23 | 26,345 | 2,284 | 1,855 | 1,145 |
| 30 Jun 23 | 24,961 | 2,311 | 1,805 | 1,177 |
| 31 Mar 23 | 25,018 | 2,809 | 1,821 | 1,068 |
| 01 Jan 23 | 24,113 | 3,294 | 1,866 | 1,014 |
| 30 Sep 22 | 23,327 | 4,019 | 1,850 | 1,263 |
| 30 Jun 22 | 23,128 | 4,508 | 1,882 | 1,246 |
| 31 Mar 22 | 21,989 | 4,677 | 1,840 | 1,165 |
| 01 Jan 22 | 20,566 | 4,676 | 1,619 | 1,010 |
| 30 Sep 21 | 19,480 | 4,170 | 1,074 | 826 |
| 30 Jun 21 | 17,623 | 3,431 | 925 | 664 |
| 31 Mar 21 | 15,066 | 2,451 | 842 | 530 |
| 31 Dec 20 | 14,112 | 2,289 | 964 | 539 |
| 30 Sep 20 | 12,989 | 2,478 | 1,204 | 491 |
| 30 Jun 20 | 12,326 | 2,617 | 1,199 | 457 |
| 31 Mar 20 | 12,274 | 2,872 | 1,169 | 425 |
| 31 Dec 19 | 11,362 | 2,594 | 1,044 | 416 |
| 30 Sep 19 | 10,691 | 2,381 | 1,084 | 465 |
| 30 Jun 19 | 10,546 | 2,215 | 1,087 | 468 |
| 31 Mar 19 | 10,674 | 2,311 | 1,084 | 448 |
| 31 Dec 18 | 10,444 | 2,286 | 1,058 | 399 |
| 30 Sep 18 | 10,731 | 2,552 | 941 | 445 |
| 30 Jun 18 | 10,559 | 2,533 | 786 | 599 |
| 31 Mar 18 | 10,456 | 2,515 | 927 | 495 |
| 31 Dec 17 | 10,258 | 2,502 | 952 | 419 |
| 30 Sep 17 | 9,657 | 2,243 | 979 | 270 |
| 30 Jun 17 | 7,797 | 1,681 | 981 | 0 |
| 31 Mar 17 | 5,857 | 1,011 | 681 | 0 |
| 31 Dec 16 | 4,136 | 442 | 561 | 0 |
| 30 Sep 16 | 2,767 | 172 | 322 | 0 |
| 30 Jun 16 | 2,612 | 136 | 297 | 0 |
| 31 Mar 16 | 2,644 | 114 | 298 | 0 |
| 31 Dec 15 | 2,635 | 111 | 295 | 0 |
| 30 Sep 15 | 2,370 | 96 | 282 | 0 |
| 30 Jun 15 | 2,324 | 98 | 289 | 0 |
| 31 Mar 15 | 2,265 | 76 | 269 | 0 |
| 31 Dec 14 | 2,051 | 63 | 240 | 0 |
| 30 Sep 14 | 2,015 | 39 | 247 | 0 |
| 30 Jun 14 | 1,981 | 34 | 217 | 0 |
| 31 Mar 14 | 1,746 | 19 | 184 | 0 |
| 31 Dec 13 | 1,723 | 24 | 167 | 0 |
| 30 Sep 13 | 1,599 | 11 | 151 | 0 |
| 30 Jun 13 | 1,460 | 32 | 130 | 0 |
Quality Earnings: 002601 has high quality earnings.
Growing Profit Margin: 002601's current net profit margins (13.1%) are higher than last year (11.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002601's earnings have grown by 6.7% per year over the past 5 years.
Accelerating Growth: 002601's earnings growth over the past year (26.6%) exceeds its 5-year average (6.7% per year).
Earnings vs Industry: 002601 earnings growth over the past year (26.6%) exceeded the Chemicals industry -21.2%.
Return on Equity
High ROE: 002601's Return on Equity (13.4%) is considered low.